Klaus F. Rabe

Also affiliated with German Center for Lung Research, LungenClinic Grosshansdorf

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype”.

Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.06.036

N/A

1.2DataRank · unranked

24 citations

J. Mark FitzGerald, Eric D. Bateman, Mario Castro, Ian Pavord, Jorge Máspero +8 more

Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19

Immunity(2020)10.1016/j.immuni.2020.11.017

N/A

0.901DataRank · unranked

405 citations

Neha Mishra, Florian Tran, Thomas Bahmer, Lena Best, Johanna I. Blase +169 more

Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(25)00044-x

N/A

0.829DataRank · unranked

24 citations

Nicola A. Hanania, Surya P. Bhatt, Mona Bafadhel, Klaus F. Rabe, Claus Vogelmeier +11 more

Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation

European Respiratory Journal(2021)10.1183/13993003.03393-2020

N/A

0.766DataRank · unranked

164 citations

Monica Kraft, Klaus F. Rabe, Yamo Deniz, Paul J. Rowe, Marcella Ruddy +2 more

Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00185-0

N/A

0.639DataRank · unranked

70 citations

E. Vanden Berghe, Monica Kraft, Judith M. Vonk, Martijn C. Nawijn, Salman Siddiqui +95 more

Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial

Respiratory Research(2020)10.1186/s12931-020-01431-y

N/A

0.573DataRank · unranked

29 citations

David Halpin, MeiLan K. Han, Marc Miravitlles, Dave Singh, Lars Grönke +3 more

Dupilumab Improves Health-Related Quality of Life and Respiratory Symptoms in Patients With COPD and Type 2 Inflammation: BOREAS and NOTUS

CHEST Journal(2025)10.1016/j.chest.2025.01.029

N/A

0.421DataRank · unranked

13 citations

Klaus F. Rabe, Nicola A. Hanania, Claus Vogelmeier, Mona Bafadhel, Stephanie A. Christenson +11 more

Early Detection of Lung Cancer Using Small RNAs

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.07.005

N/A

0DataRank · unranked

24 citations

Rastislav Horos, Franziska Trudzinski, Julia Jehn, Maurice Frank, Timothy Rajakumar +36 more

Airway specific deregulation of asthma-related serpins impairs tracheal architecture and oxygenation in D. melanogaster

Scientific Reports(2024)10.1038/s41598-024-66752-0

N/A

0DataRank · unranked

1 citations

Hanna Angstmann, Beate Höschler, Draginja Kovacevic, Barbara Hammer, Thomas Roeder +5 more

Detecting Small Airways Dysfunction in Asthma: Rationale, Findings, and Future of ATLANTIS

The Journal of Allergy and Clinical Immunology In Practice(2025)10.1016/j.jaip.2025.08.013

N/A

0DataRank · unranked

4 citations

Christopher E. Brightling, Dave Singh, Janwillem Kocks, Leonardo M. Fabbri, Alberto Papi +5 more

A response to therapy for COPD with dupilumab

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(24)00371-0

N/A

0DataRank · unranked

5 citations

Klaus F. Rabe, Dave Singh, Mona Bafadhel, Claus Vogelmeier, Surya P. Bhatt

A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

UNC Libraries(2020)10.17615/md2j-3z93

N/A

0DataRank · unranked

0 citations

James F. Donohue, Sarvajna Dwivedi, Klaus F. Rabe, Patrick Darken, Chad Orevillo +11 more

Immune Training of the Interleukin 6 Gene in Airway Epithelial Cells is Central to Asthma Exacerbations

Allergy(2025)10.1111/all.70070

N/A

0DataRank · unranked

1 citations

Markus Weckmann, Ulrich M. Zissler, Constanze A. Jakwerth, Rebecca Bodenstein‐Sgró, Sina Webering +29 more

Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre–Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward

American Journal of Respiratory and Critical Care Medicine(2021)10.1164/rccm.202107-1663so

N/A

0DataRank · unranked

161 citations

Alvar Agusti, Bartolome R. Celli, MeiLan K. Han, James P. Allinson, Surya P. Bhatt +25 more

The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(21)00536-1

N/A

0DataRank · unranked

137 citations

Matthew Richardson, Brian Hallmark, Dean Billheimer, Maarten van den Berge, Leonardo M. Fabbri +31 more

Multi‐ancestry genome‐wide association study of asthma exacerbations

Pediatric Allergy and Immunology(2022)10.1111/pai.13802

N/A

0DataRank · unranked

26 citations

Victor E. Ortega, Elizabeth J. Ampleford, Yang Yie Sio, Raquel Granell, Emmely W. de Roos +59 more

In vitro neutrophil migration is associated with inhaled corticosteroid treatment and serum cytokines in pediatric asthma

Frontiers in Pharmacology(2022)10.3389/fphar.2022.1021317

N/A

0DataRank · unranked

1 citations

Markus Weckmann, Anna Wohlers, Adan Chari Jirmo, Ruth Grychtol, Isabell Ricklefs +16 more